We also argue that this regulatory system responds to nutritional cures in the opposite direction, i.e., overnutrition in conditions such as maternal obesity and gestational diabetes, where placental mTOR signaling activation may contribute to fetal overgrowth in some cases. The gene discussed is MTOR; the disease is gestational diabetes.